Manufacturer
Wyeth Pharmaceuticals
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 30
- Molecules
- 14
- Therapy areas
- 4
Wyeth Pharmaceuticals is a pharmaceutical manufacturer based in United States. MedsAcross lists 30 of its products across 14 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Wyeth Pharmaceutical Division of Wyeth Holdings LLC, Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Wyeth Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Gastroenterology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Protonix Delayed-Release 20 mg delayed-release tabletOral | Pantoprazole | US FDA | Available on request |
| Protonix Delayed-Release 40 mg delayed-release granulesOral | Pantoprazole | US FDA | Available on request |
| Protonix Delayed-Release 40 mg delayed-release tabletOral | Pantoprazole | US FDA | Available on request |
| Protonix I.V. 40 mg/10 mL powder for injectionIntravenous | Pantoprazole | US FDA | Available on request |
Oncology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Besponsa 0.25 mg/mL powder for injectionIntravenous Cold chain | Inotuzumab ozogamicin | US FDA | Available on request |
| Mylotarg 5 mg/5 mL powder for injectionIntravenous Cold chain | Gemtuzumab ozogamicin | US FDA | Available on request |
| Torisel kit | Temsirolimus | US FDA | Available on request |
Psychiatry
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Pristiq Extended-Release 100 mg extended-release tabletOral | Desvenlafaxine | US FDA | Available on request |
| Pristiq Extended-Release 25 mg extended-release tabletOral | Desvenlafaxine | US FDA | Available on request |
| Pristiq Extended-Release 50 mg extended-release tabletOral | Desvenlafaxine | US FDA | Available on request |
Antibiotics
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Tygacil 50 mg/5 mL powder for injectionIntravenous | Tigecycline | US FDA | Available on request |
Other products
19 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Duavee 20 mg/0.45 mg tabletOral | Bazedoxifene and Estrogens, conjugated | US FDA | Available on request |
| North American Coral Snake Antivenin (Equine) 250 units/10 mL powder for injectionIntravenous Cold chain | Coral snake (micrurus fulvius) immune globulin antivenin (equine) | US FDA | Available on request |
| Premarin 0.3 mg tabletOral | Estrogens, conjugated | US FDA | Available on request |
| Premarin 0.45 mg tabletOral | Estrogens, conjugated | US FDA | Available on request |
| Premarin 0.625 mg tabletOral | Estrogens, conjugated | US FDA | Available on request |
| Premarin 0.9 mg tabletOral | Estrogens, conjugated | US FDA | Available on request |
| Premarin 1.25 mg tabletOral | Estrogens, conjugated | US FDA | Available on request |
| Premarin 25 mg/5 mL powder for injectionIntramuscular, intravenous Cold chain | Estrogens, conjugated | US FDA | Available on request |
| Premarin Vaginal 0.0625% vaginal creamVaginal | Estrogens, conjugated | US FDA | Available on request |
| Premphase kit | Conjugated estrogens and Medroxyprogesterone | US FDA | Available on request |
| Prempro 0.3 mg/1.5 mg tabletOral | Estrogens, conjugated and Medroxyprogesterone | US FDA | Available on request |
| Prempro 0.45 mg/1.5 mg tabletOral | Estrogens, conjugated and Medroxyprogesterone | US FDA | Available on request |
| Prempro 0.625 mg/2.5 mg tabletOral | Estrogens, conjugated and Medroxyprogesterone | US FDA | Available on request |
| Prempro 0.625 mg/5 mg tabletOral | Estrogens, conjugated and Medroxyprogesterone | US FDA | Available on request |
| Prevnar 20 injectable suspensionIntramuscular | Pneumococcal 20-valent conjugate vaccine | US FDA | Available on request |
| Trumenba injectable suspensionIntramuscular | Meningococcal group b vaccine | US FDA | Available on request |
| Zosyn in Galaxy Containers 2 g/250 mg per 50 mL injectionIntravenous Cold chain | Piperacillin and Tazobactam | US FDA | Available on request |
| Zosyn in Galaxy Containers 3 g/375 mg per 50 mL injectionIntravenous Cold chain | Piperacillin and Tazobactam | US FDA | Available on request |
| Zosyn in Galaxy Containers 4 g/500 mg per 100 mL injectionIntravenous Cold chain | Piperacillin and Tazobactam | US FDA | Available on request |
Molecules made
Inotuzumab ozogamicinBazedoxifene and Estrogens, conjugatedGemtuzumab ozogamicinCoral snake (micrurus fulvius) immune globulin antivenin (equine)Estrogens, conjugatedConjugated estrogens and MedroxyprogesteroneEstrogens, conjugated and MedroxyprogesteronePneumococcal 20-valent conjugate vaccineDesvenlafaxinePantoprazoleTemsirolimusMeningococcal group b vaccineTigecyclinePiperacillin and Tazobactam
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Wyeth Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.